Financial reports
10-Q
2023 Q3
Quarterly report
9 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
10-K
2022 FY
Annual report
16 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
10-K
2021 FY
Annual report
24 Mar 22
10-Q
2021 Q3
Quarterly report
28 Oct 21
Current reports
8-K
Submission of Matters to a Vote of Security Holders
26 Jan 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4 Dec 23
8-K
Departure of Directors or Certain Officers
21 Nov 23
8-K
Entry into a Material Definitive Agreement
27 Oct 23
8-K
Other Events
17 Oct 23
8-K
Departure of Directors or Certain Officers
21 Aug 23
8-K
Evelo Biosciences Announces Second Quarter Financial Results and Recent Business Highlights
14 Aug 23
8-K
Entry into a Material Definitive Agreement
20 Jul 23
8-K
Evelo Biosciences Closes $25.5 Million Private Placement
12 Jul 23
8-K
Evelo Biosciences Announces $25.5 Million Private Placement
10 Jul 23
Registration and prospectus
15-12G
Securities registration termination
26 Jan 24
S-8 POS
Registration of securities for employees (post-effective amendment)
26 Jan 24
S-8 POS
Registration of securities for employees (post-effective amendment)
26 Jan 24
POS AM
Prospectus update (post-effective amendment)
26 Jan 24
25-NSE
Exchange delisting
27 Dec 23
424B3
Prospectus supplement
21 Aug 23
S-3
Shelf registration
10 Aug 23
424B5
Prospectus supplement for primary offering
1 Jul 22
424B5
Prospectus supplement for primary offering
25 May 22
S-3
Shelf registration
23 Aug 21
Proxies
DEFA14A
Additional proxy soliciting materials
12 Dec 23
DEF 14A
Definitive proxy
12 Dec 23
PRE 14A
Preliminary proxy
1 Dec 23
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
PRE 14A
Preliminary proxy
18 Apr 23
DEFA14A
Additional proxy soliciting materials
26 Apr 22
DEF 14A
Definitive proxy
26 Apr 22
DEFA14A
Additional proxy soliciting materials
26 Apr 21
DEF 14A
Definitive proxy
26 Apr 21
Other
EFFECT
Notice of effectiveness
11 Mar 24
EFFECT
Notice of effectiveness
18 Aug 23
CORRESP
Correspondence with SEC
15 Aug 23
UPLOAD
Letter from SEC
14 Aug 23
EFFECT
Notice of effectiveness
31 Aug 21
CORRESP
Correspondence with SEC
26 Aug 21
UPLOAD
Letter from SEC
26 Aug 21
CT ORDER
Confidential treatment order
2 Aug 21
CT ORDER
Confidential treatment order
22 Mar 21
EFFECT
Notice of effectiveness
7 Jun 19